Evidence map›Paper›PMID 41786713›Full record

ArticleNature communications2026

Site-specific profiling of structure and function of Igµ B cell receptor glycans.

M D Holborough-Kerkvliet, L Hafkenscheid, S Kroos, R Biersteker, R van de Wetering, O Singh, E Fadda, R T N Tjokrodirijo, P A van Veelen, M Wuhrer and 2 more

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

M D Holborough-KerkvlietDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. M.Holborough-Kerkvliet@Sanquin.nl.ORCID http://orcid.org/0000-0002-8835-2355
L HafkenscheidDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-1622-8483
S KroosDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0001-8900-1285
R BierstekerDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-3915-3472
R van de WeteringDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0001-5330-5113
O SinghDepartment of Chemistry, Maynooth University, Maynooth, Ireland.ORCID http://orcid.org/0000-0002-2586-2542
E FaddaSchool of Biological Sciences, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0002-2898-7770
R T N TjokrodirijoCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.
P A van VeelenCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-7898-9408
M WuhrerCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-0814-4995
D FalckCenter for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0003-3908-2376
R E M ToesDepartment of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. R.E.M.Toes@LUMC.nl.ORCID http://orcid.org/0000-0002-9618-6414

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although N-linked glycans play pivotal roles in the regulation of antibody effector functions, little is known about the composition and functional impact of glycans attached to human B cell receptors (BCR). Here, we describe the site-specific glycosylation profiles of all 4 N-linked glycosylation sites of human Igµ BCRs from primary naive and memory B cells. Our data indicate that the Igµ BCR glycans do not undergo structural changes during transition from naive to memory cells, as healthy donor-derived BCRs from both B cell subtypes carry similar glycans. Conversely, serum IgM antibodies display distinct glycosylation features to Igµ BCRs, which are in part explained by the different molecular form of Igµ BCRs and IgM antibodies. Moreover, using B cell lines expressing defined BCRs, we show that, although the absence of the Igµ BCR N209 glycans reduces antigen binding, the individual glycosylation sites are nonessential for cell surface expression and BCR internalization following BCR triggering. Collectively, we show high conservation of Igµ BCR glycosylation across B cell subsets and limited contribution to BCR expression and function, suggesting BCR glycans may have evolved to support IgM antibody functions.

Indexed as

PolysaccharidesReceptors, Antigen, B-CellB-LymphocytesGlycosylationHumansImmunoglobulin MImmunoglobulin MPolysaccharidesReceptors, Antigen, B-Cell

Identifiers

PMID41786713
PMCPMC13083998

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.